Table 3.
Bivariate analysis according to the presence of fibrosis.
| Variable * | With Fb | Without Fb | p |
|---|---|---|---|
| Age (years) | 40.0 ± 11.4 (n = 83) | 34.8 ± 9.3 (n = 100) | 0.001 |
| Female | 67 (79.8) (n = 84) | 86 (80.4) (n = 107) | 1.000 |
| BMI (kg/m2) | 43.4 ± 5.4 (n = 84) | 43.9 ± 5.0 (n = 107) | 0.479 |
| Ferritin (µ/L) | 127 (81–293) (n = 73) | 109 (56–97) (n = 96) | 0.080 |
| Iron (µ/L) | 75.8 ± 22.5 (n = 73) | 76.9 ± 27.4 (n = 90) | 0.790 |
| ** AST (U/L) | 25 (19–43) (n = 83) | 24 (18–28) (n = 100) | 0.040 |
| ** ALT (U/L) | 30 (24–54) (n = 83) | 26 (19–39) (n = 100) | 0.008 |
| ** ALT > 1.5 × U/L | 19 (22.9) (n = 83) | 9 (8.9) (n = 100) | 0.015 |
| Glycemia (mg/dL) | 110.9 ± 40 (n = 83) | 98.0 ± 27.9 (n = 105) | 0.014 |
| Glycemia ≥ 126 mg/dL | 17 (20.5) (n = 83) | 7 (6.7) (n = 105) | 0.009 |
| Platelets (10³/mm3) | 273.6 ± 59.3 (n = 77) | 285 ± 70.6 (n = 95) | 0.261 |
| Total cholesterol (mg/dL) | 198.9 ± 42.3 (n = 80) | 188.7 ± 41.4 (n = 106) | 0.102 |
| LDL-C (mg/dL) | 116.3 ± 38.4 (n = 80) | 115.8 ± 43.1 (n = 106) | 0.934 |
| HDL-C (mg/dL) | 49.2 ± 14.2 (n = 80) | 48.6 ± 13.3 (n = 106) | 0.776 |
| TG (mg/dL) | 148.5 (100–199) (n = 80) | 112.5 (83.8–158) (n = 106) | 0.005 |
| TG ≥ 150 mg/dL | 40 (50) (n = 80) | 27 (25.5) (n = 106) | 0.001 |
* Variables described by mean ± standard deviation, median (percentiles 25–75) or n (%); ** Normal values for ALT: 14–42 U/L and for AST: 10–42 U/L; n = number of cases; Fb = fibrosis; BMI = body mass index; AST = aspartate aminotransferase; ALT = alanine aminotransferase; LDL-C = low density lipoprotein; HDL-C = high density lipoprotein; TG = triglycerides.